Armistice Capital Master Fund Buys 226,000 Shares of Valeritas Holdings Inc (NASDAQ:VLRX) Stock

Valeritas Holdings Inc (NASDAQ:VLRX) major shareholder Armistice Capital Master Fund acquired 226,000 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were bought at an average price of $0.66 per share, for a total transaction of $149,160.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Armistice Capital Master Fund also recently made the following trade(s):

  • On Friday, May 24th, Armistice Capital Master Fund purchased 24,000 shares of Valeritas stock. The stock was acquired at an average price of $2.27 per share, for a total transaction of $54,480.00.
  • On Friday, May 10th, Armistice Capital Master Fund purchased 100,000 shares of Valeritas stock. The stock was acquired at an average price of $0.31 per share, for a total transaction of $31,000.00.
  • On Monday, March 25th, Armistice Capital Master Fund purchased 50,000 shares of Valeritas stock. The stock was acquired at an average price of $0.33 per share, for a total transaction of $16,500.00.

NASDAQ:VLRX traded down $0.10 during trading hours on Friday, hitting $2.96. The stock had a trading volume of 88,634 shares, compared to its average volume of 209,958. The company has a quick ratio of 2.81, a current ratio of 3.32 and a debt-to-equity ratio of 29.19. Valeritas Holdings Inc has a 1-year low of $2.10 and a 1-year high of $41.60. The company has a market capitalization of $16.02 million, a price-to-earnings ratio of -0.09 and a beta of 2.24.

Valeritas (NASDAQ:VLRX) last issued its quarterly earnings data on Thursday, May 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.15). Valeritas had a negative net margin of 183.53% and a negative return on equity of 1,757.04%. The company had revenue of $6.40 million during the quarter, compared to the consensus estimate of $6.20 million. On average, equities analysts anticipate that Valeritas Holdings Inc will post -11.2 earnings per share for the current year.

Large investors have recently modified their holdings of the business. Weiss Multi Strategy Advisers LLC acquired a new stake in shares of Valeritas during the fourth quarter worth approximately $41,000. Renaissance Technologies LLC grew its position in shares of Valeritas by 730.3% during the third quarter. Renaissance Technologies LLC now owns 163,650 shares of the company’s stock worth $218,000 after buying an additional 143,940 shares in the last quarter. Northern Trust Corp grew its position in shares of Valeritas by 855.4% during the fourth quarter. Northern Trust Corp now owns 185,469 shares of the company’s stock worth $60,000 after buying an additional 166,057 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Valeritas by 138.0% during the fourth quarter. Geode Capital Management LLC now owns 186,971 shares of the company’s stock worth $60,000 after buying an additional 108,416 shares in the last quarter. Finally, Millennium Management LLC acquired a new stake in shares of Valeritas during the fourth quarter worth approximately $165,000.

Several research analysts recently commented on VLRX shares. Zacks Investment Research lowered shares of Valeritas from a “buy” rating to a “hold” rating in a report on Saturday, March 9th. ValuEngine lowered shares of Valeritas from a “buy” rating to a “hold” rating in a report on Saturday, May 18th. Finally, Oppenheimer set a $2.00 price target on shares of Valeritas and gave the company a “buy” rating in a report on Friday, May 10th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Valeritas currently has an average rating of “Buy” and a consensus target price of $2.10.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Rockland Register and is owned by of Rockland Register. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://rocklandregister.com/2019/06/14/armistice-capital-master-fund-acquires-226000-shares-of-valeritas-holdings-inc-vlrx-stock.html.

Valeritas Company Profile

Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization.

Featured Story: Mutual Funds

Insider Buying and Selling by Quarter for Valeritas (NASDAQ:VLRX)

Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.